• Nonivamide (Capsaicin Analog): Reliable TRPV1 Agonism in Can

  2026-05-24

  This article addresses real-world challenges in cell viability and cytotoxicity assays, illustrating how Nonivamide (Capsaicin Analog), SKU A3278, delivers reproducible, mechanistically validated solutions for cancer and neuroimmune research. Scenario-driven Q&A blocks detail its application in glioma and SCLC models, protocol optimization, and vendor selection, with evidence-rooted recommendations and workflow best practices.

• WZ4003: Advancing NUAK1/2 Inhibitor Workflows for Cell Migra

  2026-05-23

  WZ4003 stands out as a highly selective NUAK1/2 inhibitor, enabling researchers to dissect cell migration, proliferation, and tau phosphorylation with unprecedented specificity. Applied in both cancer and neurodegenerative disease models, it bridges mechanistic studies with translational impact, as highlighted by recent breakthroughs in tau-targeted research.

• TBK1 Inhibition Attenuates Painful Diabetic Neuropathy via M

  2026-05-22

  The referenced study elucidates the mechanistic role of TBK1 in promoting painful diabetic neuropathy (PDN) through microglial pyroptosis, and demonstrates that pharmacological or genetic inhibition of TBK1 alleviates PDN in murine models. These findings open new avenues for targeting neuroinflammation in diabetes complications and reinforce the value of robust experimental models for translational research.

• Reactive Oxygen Species Assay Kit: Precision in Live Cell RO

  2026-05-22

  Leverage the Reactive Oxygen Species Assay Kit to achieve sensitive, quantitative ROS detection in live cells, crucial for deciphering oxidative stress mechanisms in cancer and immunotherapy research. Discover advanced workflow enhancements, troubleshooting guidance, and the practical impact of recent breakthroughs in ROS-driven tumor biology.

• (S)-Mephenytoin: Gold-Standard CYP2C19 Substrate for Drug Me

  2026-05-21

  (S)-Mephenytoin is a rigorously characterized CYP2C19 substrate crucial for benchmarking cytochrome P450 metabolism and pharmacokinetic studies. Its high purity, defined kinetic parameters, and reliable in vitro performance make it a preferred reagent for evaluating human drug metabolism pathways.

• ac4C Modification in lncRNA Gm26917 Regulates Germline Stem

  2026-05-21

  This study reveals that N4-acetylcytidine (ac4C) modification on the long noncoding RNA Gm26917 is essential for maintaining female germline stem cell (FGSC) translation efficiency and self-renewal. By uncovering the ac4C-Gm26917–EEF1A1–Rpl10 axis, the research provides new insights into post-transcriptional regulation mechanisms and potential targets for fertility modulation.

• Aneugenic Mechanism Profiling: Insights from 27 Reference Ch

  2026-05-20

  This study introduces a robust, tiered molecular assay to discriminate the main mechanisms underlying chemical-induced aneugenicity in TK6 cells, specifically distinguishing tubulin stabilization/destabilization and mitotic kinase inhibition. The work offers a practical framework for elucidating genotoxic mechanisms and sets a benchmark for integrating machine learning in mechanistic genotoxicity screening.

• Enhanced ECL Detection: Transforming Translational RCC Resea

  2026-05-20

  This thought-leadership article explores how the ECL Chemiluminescent Substrate Detection Kit (Enhanced) from APExBIO empowers translational researchers to decode metabolic mechanisms and overcome drug resistance in renal cell carcinoma (RCC). By weaving together mechanistic insights, experimental strategies, and workflow optimization, the article provides actionable guidance for leveraging ultra-sensitive western blot chemiluminescence detection to accelerate breakthroughs in oncology.

• Angiotensin I: Applied Protocols in Renin-Angiotensin System

  2026-05-19

  Harness Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) for precise cardiovascular and neuroendocrine pathway modeling. This guide delivers actionable protocols, troubleshooting insights, and cross-domain considerations, leveraging APExBIO’s rigorously validated product to advance translational research and antihypertensive drug screening.

• Reliable Pseudo-UTP (SKU B7972): Enhancing mRNA Synthesis Wo

  2026-05-19

  This article provides a scenario-driven, evidence-based guide to integrating Pseudo-UTP (SKU B7972) into RNA synthesis workflows. By addressing real laboratory challenges, it demonstrates how this pseudo-modified uridine triphosphate supports reproducibility and robustness in mRNA vaccine, gene therapy, and cell viability assays. Researchers gain practical insights rooted in literature and validated protocols.

• Xin Jia Congrong Tusizi Decoction Suppresses Ferroptosis in

  2026-05-18

  This study uncovers how the traditional Chinese formula Xin Jia Congrong Tusizi Decoction (XJCTD) protects against ovarian function decline by suppressing ferroptosis in granulosa cells. The findings highlight a p53/Nrf2/SLC7A11/GPX4-dependent mechanism and offer a molecular basis for developing targeted interventions in reproductive aging and oxidative stress disorders.

• ECL Western Blotting Substrate: Technical Protocol and Best

  2026-05-18

  ECL Western Blotting Substrate (SKU K2187) provides a nonradioactive, luminol-based solution for sensitive detection of horseradish peroxidase in immunoblots. It is optimized for Western blot assays in molecular and cancer biology but should not be used for workflows requiring fluorescent or radioisotopic detection.

• WEHI-539: Selective BCL-XL Inhibitor for Apoptosis Research

  2026-05-17

  WEHI-539 is a potent BCL-XL inhibitor with subnanomolar affinity, enabling precise induction of apoptosis in BCL-XL-dependent cell models. Its selectivity and robust benchmarking support its utility in dissecting apoptotic resistance and cancer stem cell sensitization.

• Itaconic Acid Restrains IFN-I Responses via TBK1 Alkylation

  2026-05-16

  Chai et al. (2025) reveal a metabolic feedback mechanism where IRG1-derived itaconic acid suppresses TBK1-driven type I interferon (IFN-I) responses by alkylating TBK1 at Cys605, disrupting its dimerization and activity. This finding bridges immunometabolism and antiviral signaling, offering new leads for controlling hyperinflammation and suggesting broader implications for pathway-targeted inhibitors.

• Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) Protocol Gu

  2026-05-15

  Angiotensin II (SKU A1042) is a validated octapeptide reagent for robust modeling of hypertension, vascular smooth muscle cell hypertrophy, and cardiovascular remodeling in preclinical research. It is not suitable for diagnostic or clinical applications and should be used following controlled laboratory protocols for data reliability.

450 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page